Literature DB >> 20456544

Cutaneous non-tuberculous Mycobacterial infections: a clinical and histopathological study of 17 cases from Lebanon.

O Abbas1, N Marrouch, M M Kattar, S Zeynoun, A G Kibbi, R A Rached, G F Araj, S Ghosn.   

Abstract

BACKGROUND: Only a few studies characterized cutaneous non-tuberculous Mycobacterium (NTM) infections in this region of the world. Objective  The aim of this study was to describe the epidemiological, clinical and histological findings of cutaneous NTM infections in Lebanon. PATIENTS/
METHODS: Retrospective study of 17 patients (19 histological specimens) diagnosed with cutaneous NTM infections and confirmed by culture-based partial sequencing of the 16S rRNA gene at the American University of Beirut Medical Center between 2005 and 2008.
RESULTS: Of 17 cases, 14 were caused by Mycobacterium marinum. All patients were immunocompetent except for one. Clinically, the most common presentation was multiple sporotrichoid lesions over an extremity (8/17). Many patients had peculiar presentations including bruise-like patches, herpetiform lesions, annular ulcerated plaques, symmetrical nodules over the buttocks and locally disseminated lesions with surrounding pale halo. Almost all patients cleared their infection on either minocycline or clarithromycin monotherapies. Histologically, a dermal small vessel proliferation with mixed inflammation (granulation tissue-like changes) was identified in 58% of specimens. The most common type of granulomatous inflammation was the suppurative (47%) followed by the tuberculoid (30%), sarcoidal (11%), and palisading (5%) types. Lichenoid granulomatous dermatitis was noted in 42% of cases. Special staining highlighted mycobacteria in only two specimens.
CONCLUSIONS: The incidence of cutaneous NTM infections is high in our area. Many patients had peculiar clinical presentations. Our study is the second to report the common presence of granulation tissue-like changes as a good histological indicator of cutaneous NTM infections. Minocycline and clarithromycin remain the drugs of choice in our area.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20456544     DOI: 10.1111/j.1468-3083.2010.03684.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

Review 1.  Twenty-eight cases of Mycobacterium marinum infection: retrospective case series and literature review.

Authors:  Matthew G Johnson; Jason E Stout
Journal:  Infection       Date:  2015-04-14       Impact factor: 3.553

2.  Mycobacterium marinum Infection Spreading in a "Birds in Flocks" Pattern: All Caseating Granuloma is Not Tuberculosis.

Authors:  Jong Bin Park; Seol Hwa Seong; Do Ik Kwon; Ji Yun Jang; Kee Suck Suh; Min Soo Jang
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

3.  Fishing for a Diagnosis, the Impact of Delayed Diagnosis on the Course of Mycobacterium marinum Infection: 21 Years of Experience at a Tertiary Care Hospital.

Authors:  Natalia E Castillo; Pooja Gurram; M Rizwan Sohail; Madiha Fida; Omar Abu Saleh
Journal:  Open Forum Infect Dis       Date:  2020-01-04       Impact factor: 3.835

Review 4.  General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection.

Authors:  Sonia Faria; Ines Joao; Luisa Jordao
Journal:  J Pathog       Date:  2015-11-04

5.  Mycobacterium marinum infections in Denmark from 2004 to 2017: A retrospective study of incidence, patient characteristics, treatment regimens and outcome.

Authors:  Inge K Holden; Michala Kehrer; Aase B Andersen; Christian Wejse; Erik Svensson; Isik Somuncu Johansen
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

6.  Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review.

Authors:  Phatcharawat Chirasuthat; Korn Triyangkulsri; Suthinee Rutnin; Kumutnart Chanprapaph; Vasanop Vachiramon
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.